| __timestamp | Rhythm Pharmaceuticals, Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1213000 | 6795238 |
| Thursday, January 1, 2015 | 3425000 | 7454247 |
| Friday, January 1, 2016 | 6311000 | 10345862 |
| Sunday, January 1, 2017 | 9518000 | 16984203 |
| Monday, January 1, 2018 | 28080000 | 16187290 |
| Tuesday, January 1, 2019 | 36550000 | 9299233.54 |
| Wednesday, January 1, 2020 | 46125000 | 19232000 |
| Friday, January 1, 2021 | 68486000 | 23611000 |
| Saturday, January 1, 2022 | 92032000 | 26700000 |
| Sunday, January 1, 2023 | 117532000 | 28215000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, managing expenses is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Summit Therapeutics Inc. and Rhythm Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Rhythm Pharmaceuticals saw a staggering increase in SG&A expenses, growing nearly 97 times from 2014 to 2023. In contrast, Summit Therapeutics experienced a more modest growth, with expenses rising by approximately 4 times.
By 2023, Rhythm Pharmaceuticals' SG&A expenses were over four times higher than those of Summit Therapeutics, highlighting a significant divergence in their financial strategies. This trend may reflect differing business models or market strategies, with Rhythm potentially investing more heavily in marketing and administrative functions. Understanding these financial dynamics provides valuable insights into the operational priorities of these two biotech firms.
Selling, General, and Administrative Costs: United Therapeutics Corporation vs Summit Therapeutics Inc.
Neurocrine Biosciences, Inc. and Summit Therapeutics Inc.: SG&A Spending Patterns Compared
Intra-Cellular Therapies, Inc. vs Summit Therapeutics Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Summit Therapeutics Inc. vs Merus N.V. Trends and Insights
Summit Therapeutics Inc. and HUTCHMED (China) Limited: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Rhythm Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs MorphoSys AG
Rhythm Pharmaceuticals, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Rhythm Pharmaceuticals, Inc. or ImmunityBio, Inc.
Selling, General, and Administrative Costs: Rhythm Pharmaceuticals, Inc. vs Dynavax Technologies Corporation
Rhythm Pharmaceuticals, Inc. and Galapagos NV: SG&A Spending Patterns Compared